{"disease":{"id":"vascular-system-injuries","name":"vascular system injuries"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04937868","title":"Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT03598140","title":"Sildenafil Treatment for Mild TBI","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":22,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":true},{"nct_id":"NCT03631056","title":"Individual Patient Expanded Access for Acellular Tissue Engineered Vessel (ATEV) for Vascular System Injuries","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"Humacyte, Inc.","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}